Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

November 02, 2017 09:00 ET | Source: CareDx, Inc.

CareDx to Participate in Upcoming Investor Conferences

BRISBANE, Calif., Nov. 02, 2017 (GLOBE NEWSWIRE) -- CareDx, Inc. (Nasdaq:CDNA), a molecular diagnostics company focused on the discovery, development and commercialization of clinically...
October 31, 2017 09:00 ET | Source: CareDx, Inc.

CareDx Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)

BRISBANE, Calif., Oct. 31, 2017 (GLOBE NEWSWIRE) -- CareDx, Inc. (Nasdaq:CDNA), a molecular diagnostics company focused on the discovery, development and commercialization of clinically...
October 30, 2017 08:00 ET | Source: CareDx, Inc.

AlloSure data will be presented at ASN

BRISBANE, Calif., Oct. 30, 2017 (GLOBE NEWSWIRE) -- CareDx, Inc. (Nasdaq:CDNA), a molecular diagnostics company focused on the discovery, development and commercialization of clinically...
October 27, 2017 09:00 ET | Source: CareDx, Inc.

CareDx to Announce Third Quarter 2017 Financial Results on November 9, 2017

BRISBANE, Calif., Oct. 27, 2017 (GLOBE NEWSWIRE) -- CareDx, Inc. (Nasdaq:CDNA), a molecular diagnostics company focused on the discovery, development and commercialization of clinically...
October 10, 2017 16:00 ET | Source: CareDx, Inc.

CareDx Announces Closing of Public Offering of Common Stock

BRISBANE, Calif., Oct. 10, 2017 (GLOBE NEWSWIRE) -- CareDx, Inc. (Nasdaq:CDNA), a molecular diagnostics company focused on the discovery, development and commercialization of clinically...
September 26, 2017 08:30 ET | Source: CareDx, Inc.

MolDX sets AlloSure reimbursement at 2017 AlloMap level

BRISBANE, Calif., Sept. 26, 2017 (GLOBE NEWSWIRE) -- CareDx, Inc. (NASDAQ:CDNA), a molecular diagnostics company focused on the discovery, development and commercialization of clinically...
September 22, 2017 17:26 ET | Source: CareDx, Inc.

AlloMap’s Medicare reimbursement to increase in 2018

BRISBANE, Calif., Sept. 22, 2017 (GLOBE NEWSWIRE) -- CareDx, Inc. (NASDAQ:CDNA), a molecular diagnostics company focused on the discovery, development and commercialization of clinically...
August 24, 2017 13:04 ET | Source: CareDx, Inc.

CareDx Confirms AlloSure Will Receive Medicare Coverage Effective October 9th, 2017

BRISBANE, Calif., Aug. 24, 2017 (GLOBE NEWSWIRE) -- CareDx, Inc. (NASDAQ:CDNA), a molecular diagnostics company focused on the discovery, development and commercialization of clinically...
August 15, 2017 08:00 ET | Source: CareDx, Inc.

CareDx to Participate in Upcoming Investor Conferences

BRISBANE, Calif., Aug. 15, 2017 (GLOBE NEWSWIRE) -- CareDx, Inc. (Nasdaq:CDNA), a molecular diagnostics company focused on the discovery, development and commercialization of clinically...
August 10, 2017 16:01 ET | Source: CareDx, Inc.

CareDx Reports Second Quarter 2017 Financial Results

BRISBANE, Calif., Aug. 10, 2017 (GLOBE NEWSWIRE) -- CareDx, Inc. (Nasdaq:CDNA), a molecular diagnostics company focused on the discovery, development and commercialization of clinically...